INDEPENDENT NEWS

AFT welcomes new codeine medicine restrictions

Published: Thu 5 Dec 2019 09:41 AM
AFT Pharmaceuticals (NZX; AFT, ASX; AFP) today welcomes Medsafe’s decision to classify all medicines containing codeine as prescription medicines.
AFT Pharmaceutical’s Managing Director Dr Hartley Atkinson said the New Zealand medicine regulator’s decision was a good result not only for AFT, but also for the country. It would increase demand for AFT’s patented pain relief medicine Maxigesic® and it would also reduce codeine overdoses and poisonings.
Dr Atkinson said: “Maxigesic was developed as a better alternative for pain relief than other combination painkiller products, particularly those containing codeine.
“In the 12 months after Australia rescheduled codeine containing medicines in 2018, sales of Maxigesic tablets increased by more than 50%. Meanwhile, the decision saw a large and significant drop in codeine poisoning calls and this drop began following the announcement and prior to legislative change .
“While Medsafe still has to set the timeframe and programme for the implementation of the new restrictions, it is clear that the harm that comes from access without a prescription to the medicine would now start to ease.”
Dr Atkinson said although AFT expected the decision to drive an increase in Maxigesic sales, it was too early to make precise predictions on the extent of the uplift although some impact on Maxigesic sales in New Zealand would be expected during the FY21 financial year.

Next in Business, Science, and Tech

Third Snapshot Report Reveals $9.5 Billion Business Investment In Climate Action
By: BusinessNZ
The home printer market is broken
By: Digitl
SFO Commences Enquiries Into Allegations Of COVID-19 Wage Subsidy Fraud
By: Serious Fraud Office
Companies In Hot Water For Selling Unsafe Hot Water Bottles And Toys
By: Commerce Commission
Robust Balance Sheets Yield Faster Economic Recovery
By: The Reserve Bank of New Zealand
Transpower Releases Independent Report Into Events Of August 9
By: Transpower
View as: DESKTOP | MOBILE © Scoop Media